WRAP53 promotes cancer cell survival and is a potential target for cancer therapy

Cell Death and Disease

Volumn 2, Issue 1, 2011, Pages

  Mahmoudi, S ^a   Henriksson, S ^a   Farnebo, L ^b   Roberg, K ^b   Farnebo, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Head and neck cancer; Mitochondrial dependent apoptosis; Oncogene; TCAB1; Wdr79; WRAP53

Indexed keywords

CYTOCHROME C; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; REGULATOR PROTEIN; UNCLASSIFIED DRUG; WRAP53 PROTEIN; TELOMERASE; TELOMERASE CAJAL BODY PROTEIN 1, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE OVEREXPRESSION; GENE SILENCING; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; UPREGULATION; ANIMAL; CELL STRAIN 3T3; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; NEOPLASM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MITOCHONDRIA; NEOPLASMS; NIH 3T3 CELLS; TELOMERASE;

EID: 79959961938     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.90     Document Type: Article

References (29)

1. Mahmoudi S, Henriksson S, Corcoran M, Mendez-Vidal C, Wiman KG, Farnebo M. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell 2009; 33: 462-471.
2. Mahmoudi S, Henriksson S, Weibrecht I, Smith S, Söderberg O, Strömblad S et al. WRAP53 is essential for Cajal Body formation and for targeting the survival of motor neuron complex to Cajal Bodies. PLoS Biology 2010; 8: e1000521.
3. Cioce M, Lamond AI. Cajal bodies: a long history of discovery. Annu Rev Cell Dev Biol 2005; 21: 105-131. (Pubitemid 41740629)
4. Cristofari G, Adolf E, Reichenbach P, Sikora K, Terns RM, Terns MP et al. Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. Mol Cell 2007; 27: 882-889. (Pubitemid 47488182)
5. Gall JG. Cajal bodies: the first 100 years. Annu Rev Cell Dev Biol 2000; 16: 273-300. (Pubitemid 32037508)
6. Tycowski KT, Shu MD, Kukoyi A, Steitz JA. A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles. Mol Cell 2009; 34: 47-57.
7. Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD et al. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 2009; 323: 644-648.
8. Garcia-Closas M, Kristensen V, Langerod A, Qi Y, Yeager M, Burdett L et al. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int J Cancer 2007; 121: 2532-2538. (Pubitemid 350022425)
9. Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009; 69: 2349-2357.
10. Weinstein IB, Joe A. Oncogene addiction. Cancer Res 2008; 68: 3077-3080; discussion 3080.
11. Tucker KE, Berciano MT, Jacobs EY, LePage DF, Shpargel KB, Rossire JJ et al. Residual Cajal bodies in coilin knockout mice fail to recruit Sm snRNPs and SMN, the spinal muscular atrophy gene product. J Cell Biol 2001; 154: 293-307. (Pubitemid 34286141)
12. Collier S, Pendle A, Boudonck K, van Rij T, Dolan L, Shaw P. A distant coilin homologue is required for the formation of cajal bodies in Arabidopsis. Mol Biol Cell 2006; 17: 2942-2951. (Pubitemid 43993499)
13. Walker MP, Tian L, Matera AG. Reduced viability, fertility and fecundity in mice lacking the cajal body marker protein, coilin. PLoS One 2009; 4: e6171.
14. Liu J, Wu LZ, Nizami Z, Deryusheva S, Rajendra TK, Beumer KJ et al. Coilin is essential for Cajal body organization in Drosophila melanogaster Cajal body. Mol Biol Cell 2009; 20: 1661-1670.
15. Whittom AA, Xu H, Hebert MD. Coilin levels and modifications influence artificial reporter splicing. Cell Mol Life Sci 2008; 65: 1256-1271.
16. Ilangovan R, Marshall WL, Hua Y, Zhou J. Inhibition of apoptosis by Z-VAD-fmk in SMN-depleted S2 cells. J Biol Chem 2003; 278: 30993-30999. (Pubitemid 36994612)
17. Parker GC, Li X, Anguelov RA, Toth G, Cristescu A, Acsadi G. Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy. Neurotox Res 2008; 13: 39-48.
18. Trulzsch B, Garnett C, Davies K, Wood M. Knockdown of SMN by RNA interference induces apoptosis in differentiated P19 neural stem cells. Brain Res 2007; 1183: 1-9. (Pubitemid 350088691)
19. Vyas S, Bechade C, Riveau B, Downward J, Triller A. Involvement of survival motor neuron (SMN) protein in cell death. Hum Mol Genet 2002; 11: 2751-2764. (Pubitemid 35221301)
20. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 1999; 18: 1219-1226. (Pubitemid 29085995)
21. Kyo S, Takakura M, Fujiwara T, Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 2008; 99: 1528-1538.
22. Velazquez-Fernandez D, Laurell C, Saqui-Salces M, Pantoja JP, Candanedo-Gonzalez F, Reza-Albarran A et al. Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): primary parathyroid hyperplasia versus adenoma. World J Surg 2006; 30: 705-713. (Pubitemid 43724097)
23. Zhang Y, Eberhard DA, Frantz GD, Dowd P, Wu TD, Zhou Y et al. GEPIS - quantitative gene expression profiling in normal and cancer tissues. Bioinformatics 2004; 20: 2390-2398. (Pubitemid 39429910)
24. Chang S, DePinho RA. Telomerase extracurricular activities. Proc Natl Acad Sci USA 2002; 99: 12520-12522.
25. Cong Y, Shay JW. Actions of human telomerase beyond telomeres. Cell Res 2008; 18: 725-732. (Pubitemid 351948231)
26. Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, Jorcano JL et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 2001; 20: 2619-2630. (Pubitemid 32938547)
27. Cayuela ML, Flores JM, Blasco MA. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression. EMBO Rep 2005; 6: 268-274. (Pubitemid 40485624)
28. Shammas MA, Koley H, Batchu RB, Bertheau RC, Protopopov A, Munshi NC et al. Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 2005; 4: 24.
29. Roberg K, Ceder R, Farnebo L, Norberg-Spaak L, Grafstrom RC. Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture. Differentiation 2008; 76: 868-880.